Neutrogena Clinical Lifting Wrinkle Treatment System description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Neutrogena Clinical Lifting Wrinkle Treatment System

Neutrogena Corporation

Neutrogena clinical™ lifting wrinkle treatment systemSPF 30 Day Activitating Cream


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Warning

For external use only. Avoid contact with eyes. If contact occurs, flush thoroughly with water. Discontinue use if irritation or rash appear.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Active Ingredients

Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 5%, Oxybenzone 3%

Inactive Ingredients

Water
Butylene Glycol
C12-15 Alkyl Benzoate
Tetrahydroxypropyl Ethylenediamine
Silica
Cetearyl Alcohol
Cyclopentasiloxane
Dimethicone
Steareth-2
Glyceryl Stearate
Steareth-21
Aluminum Starch Octenylsuccinate
Cetearyl Glucoside
C13-14 Isoparaffin
Dimethicone/Vinyl Dimethicone Crosspolymer
Arachidyl Alcohol
PEG-100 Stearate
Disodium EDTA
Polyacrylamide
Behenyl Alcohol
Acrylates/C10-30 Alkyl Acrylate Crosspolymer
Propylparaben
Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate
Arachidyl Glucoside
Laureth-7
Citric Acid
Benzyl Alcohol
Phenoxyethanol
Methylparaben
Ethylparaben
Fragrance

Questions

1-800-582-4048 or www.neutrogena.com

PRINCIPAL DISPLAY PANEL - Kit Carton

NEW

Neutrogena
clinical

lifting wrinkle treatment system

visibly smoothes wrinkles and firms
for a resilient, youthful look

STARTER SYSTEM
SPF 30 EYE

helloplex®

with
ion2complex

gel serum    +   spf 30 activating  +  
cream
eye activating
cream

GEL SERUM 0.5 FL OZ (14mL) • SPF 30 ACTIVATING CREAM 0.33 FL OZ (10mL)
EYE ACTIVATING CREAM 0.17 FL OZ (5mL)

Neutrogena Clinical Lifting Wrinkle Treatment System

Neutrogena Clinical Lifting Wrinkle Treatment System

Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone CREAM

Product Information

Product Type Human otc drug label Item Code (Source) NDC:10812-130
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
AVOBENZONE AVOBENZONE 30 mg
HOMOSALATE Homosalate 120 mg
OCTISALATE OCTISALATE 50 mg
OCTOCRYLENE Octocrylene 50 mg
OXYBENZONE OXYBENZONE 30 mg

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 10 in 1 BOTTLE, PUMP
2 NDC:10812-130-90 1 in 1 KIT

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2010-04-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.